Nouscom Names Loredana Siani As CTO
· pulse2.com · popularity 15/100 · 0 similar stories today · Genetics, Genomics & Biotech (Science)
Read the original at pulse2.com →
Summary
Nouscom, a clinical-stage biotechnology company developing cancer immunotherapies, has promoted Loredana Siani, Ph.D., to Chief Technology Officer following its recently announced €120 million ($135 million) Series D financing. The post Nouscom Names Loredana Siani As CTO appeared first on Pulse 2.0 .
Found in: Pulse 2.0. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 20.